<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Usual doses of combined inhaled glucocorticoids and bronchodilators</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Usual doses of combined inhaled glucocorticoids and bronchodilators</h1>
<div class="graphic"><div class="figure"><div class="ttl">Usual doses of combined inhaled glucocorticoids and bronchodilators</div><div class="cntnt"><table cellspacing="0"><colgroup span="4" width="25%"></colgroup> <tbody> <tr> <td class="subtitle1">Medication</td> <td class="subtitle1">Low dose</td> <td class="subtitle1">Medium dose</td> <td class="subtitle1">High dose</td> </tr> <tr> <td class="subtitle2_left" colspan="4">ICS-SABA combination</td> </tr> <tr> <td class="indent1" colspan="4"><strong>Budesonide-albuterol HFA (Brand name:</strong> <span class="nowrap_whitespace"><strong>Airsupra)</strong>*</span></td> </tr> <tr> <td class="indent1" colspan="4"> <p>NOTE: Not used for maintenance therapy.</p> Acute symptom relief: Budesonide-albuterol (80 mcg/90 mcg) 2 inhalations as needed (usual maximum: 12 inhalations/day).</td> </tr> <tr> <td class="subtitle2_left" colspan="4">ICS-LABA combinations</td> </tr> <tr> <td class="indent1" colspan="4"><strong>Beclomethasone [beclometasone]-formoterol DPI or HFA (Not available in United States or Canada, but available elsewhere [sample brand names: Formodual, Fostair,</strong> <span class="nowrap_whitespace"><strong>Foster])</strong><sup>¶</sup><sup>Δ</sup></span></td> </tr> <tr> <td class="indent2">100 mcg/6 mcg</td> <td>1 inhalation twice a day</td> <td>2 inhalations twice a day</td> <td> </td> </tr> <tr> <td class="indent2">200 mcg/6 mcg</td> <td> </td> <td> </td> <td>2 inhalations twice a day</td> </tr> <tr> <td class="indent1" colspan="4"><strong>Budesonide-formoterol HFA (Brand names:</strong> <span class="nowrap_whitespace"><strong>Symbicort, Breyna)</strong><sup>¶</sup></span></td> </tr> <tr> <td class="indent2">80 mcg/4.5 mcg</td> <td>2 inhalations twice a day</td> <td> </td> <td> </td> </tr> <tr> <td class="indent2">160 mcg/4.5 mcg</td> <td> </td> <td>2 inhalations twice a day</td> <td> </td> </tr> <tr> <td class="indent1" colspan="4"><strong>Fluticasone furoate-vilanterol DPI (Brand name: Breo</strong> <span class="nowrap_whitespace"><strong>Ellipta)</strong><sup>Δ</sup></span></td> </tr> <tr> <td class="indent1" colspan="4">NOTE: Inhaled fluticasone furoate has a greater anti-inflammatory potency per microgram than fluticasone propionate inhalers. Thus, fluticasone furoate is administered at a lower daily dose and used only <strong>once</strong> daily.</td> </tr> <tr> <td class="indent2">50 mcg/25 mcg<sup>◊</sup></td> <td> 1 inhalation once daily</td> <td> </td> <td> </td> </tr> <tr> <td class="indent2">100 mcg/25 mcg</td> <td> </td> <td>1 inhalation once daily</td> <td> </td> </tr> <tr> <td class="indent2">200 mcg/25 mcg</td> <td> </td> <td> </td> <td>1 inhalation once daily</td> </tr> <tr> <td class="indent1" colspan="4"><strong>Fluticasone propionate-formoterol MDI (Not available in United States or Canada, but available elsewhere [sample brand name: Flutiform])</strong></td> </tr> <tr> <td class="indent2">50 mcg/5 mcg</td> <td>2 inhalations twice daily</td> <td> </td> <td> </td> </tr> <tr> <td class="indent2">125 mcg/5 mcg</td> <td> </td> <td>2 inhalations twice daily</td> <td> </td> </tr> <tr> <td class="indent2">250 mcg/10 mcg</td> <td> </td> <td> </td> <td>2 inhalations twice daily</td> </tr> <tr> <td class="indent1" colspan="4"><strong>Fluticasone propionate-salmeterol DPI (Brand names: Advair Diskus, Wixela</strong> <span class="nowrap_whitespace"><strong>Inhub)</strong><sup>Δ</sup></span></td> </tr> <tr> <td class="indent2">100 mcg/50 mcg</td> <td>1 inhalation twice a day</td> <td> </td> <td> </td> </tr> <tr> <td class="indent2">250 mcg/50 mcg</td> <td> </td> <td>1 inhalation twice a day</td> <td> </td> </tr> <tr> <td class="indent2">500 mcg/50 mcg</td> <td> </td> <td> </td> <td>1 inhalation twice a day</td> </tr> <tr> <td class="indent1" colspan="4"><strong>Fluticasone propionate-salmeterol HFA (Brand name: Advair HFA)</strong></td> </tr> <tr> <td class="indent2">45 mcg/21 mcg</td> <td>2 inhalations twice a day</td> <td> </td> <td> </td> </tr> <tr> <td class="indent2">115 mcg/21 mcg</td> <td> </td> <td>2 inhalations twice a day</td> <td> </td> </tr> <tr> <td class="indent2">230 mcg/21 mcg</td> <td> </td> <td> </td> <td>2 inhalations twice a day</td> </tr> <tr> <td class="indent1" colspan="4"><strong>Fluticasone propionate-salmeterol DPI (Brand names: AirDuo RespiClick, AirDuo</strong> <span class="nowrap_whitespace"><strong>Digihaler)</strong><sup>Δ</sup><sup>§</sup></span></td> </tr> <tr> <td class="indent2">55 mcg/14 mcg</td> <td>1 inhalation twice a day</td> <td> </td> <td> </td> </tr> <tr> <td class="indent2">113 mcg/14 mcg</td> <td>1 inhalation twice a day</td> <td>1 inhalation twice a day</td> <td> </td> </tr> <tr> <td class="indent2">232 mcg/14 mcg</td> <td> </td> <td> </td> <td>1 inhalation twice a day</td> </tr> <tr> <td class="indent1" colspan="4"><strong>Mometasone-formoterol HFA (Brand name: Dulera)</strong></td> </tr> <tr> <td class="indent2">100 mcg/5 mcg</td> <td> </td> <td>2 inhalations twice a day</td> <td> </td> </tr> <tr> <td class="indent2">200 mcg/5 mcg</td> <td> </td> <td> </td> <td>2 inhalations twice a day</td> </tr> <tr> <td class="indent1" colspan="4"><strong>Mometasone-indacaterol DPI (Brand name: Atectura Breezhaler; available in</strong> <span class="nowrap_whitespace"><strong>Canada)</strong><sup>Δ</sup></span></td> </tr> <tr> <td class="indent2">80 mcg/150 mcg</td> <td>1 inhalation (capsule) once a day</td> <td> </td> <td> </td> </tr> <tr> <td class="indent2">160 mcg/150 mcg</td> <td> </td> <td>1 inhalation (capsule) once a day</td> <td> </td> </tr> <tr> <td class="indent2">320 mcg/150 mcg</td> <td> </td> <td> </td> <td>1 inhalation (capsule) once a day</td> </tr> <tr> <td class="subtitle2_left" colspan="4">ICS-LAMA-LABA combinations<sup>¥</sup></td> </tr> <tr> <td class="indent1" colspan="4"><strong>Fluticasone furoate-umeclidinium-vilanterol DPI (Brand name: Trelegy</strong> <span class="nowrap_whitespace"><strong>Ellipta)</strong><sup>Δ</sup></span></td> </tr> <tr> <td class="indent2">100 mcg/62.5 mcg/25 mcg</td> <td> </td> <td>1 inhalation once daily</td> <td> </td> </tr> <tr> <td class="indent2">200 mcg/62.5 mcg/25 mcg</td> <td> </td> <td> </td> <td>1 inhalation once daily</td> </tr> <tr> <td class="indent1" colspan="4"><strong>Mometasone-glycopyrrolate (glycopyrronium)-indacaterol DPI (Brand name: Enerzair Breezhaler; available in</strong> <span class="nowrap_whitespace"><strong>Canada)</strong>*<sup>Δ</sup></span></td> </tr> <tr> <td class="indent2">160 mcg/50 mcg/150 mcg</td> <td> </td> <td> </td> <td>1 inhalation (capsule) once a day</td> </tr> </tbody></table></div><div class="graphic_lgnd">Do not exceed the maximum number of inhalations/puffs per day listed in the table due to the risk of toxicity from an excess dose of long-acting beta-agonist (ie, salmeterol, formoterol, or vilanterol). Brand names and dose per puff or per inhalation of commercially available fixed dose combinations are according to United States prescribing information, unless otherwise noted. Consult local product information before use.</div><div class="graphic_footnotes"><p>ICS: inhaled glucocorticoid (inhaled corticosteroid); SABA: short-acting beta-agonist; LABA: long-acting beta-agonist; LAMA: long-acting muscarinic antagonist; HFA: metered dose inhaler with hydrofluoroalkane propellant; DPI: dry powder inhaler; SMI: soft mist inhaler.</p>
<p>* Not approved for use in patients &lt;18 years old.</p>
<p>¶ When using ICS-formoterol as reliever, use one to two inhalations as needed. Maximum daily dose of maintenance and rescue is 12 inhalations.</p>
<p>Δ DPI contains lactose which may have small amounts of milk protein.</p>
<p>◊ Fluticasone furoate-vilanterol 50 mcg/25 mcg DPI is approved for use in patients 5 to 11 years old; use in adolescents and adults is off-label.</p>
<p>§ In AirDuo inhalers, the daily dose of salmeterol is approximately one-fourth of the dose in Advair, and the daily dose of fluticasone is approximately one-half that of the comparable low-, medium-, and high-dose strengths of Advair.</p>
¥ Alternatively, tiotropium SMI (Brand name: Spiriva Respimat) can be used with an ICS or ICS-LABA inhaler. The dose in asthma is two inhalations (1.25 mcg/inhalation) once daily.</div><div class="graphic_reference">Reference: Global Initiative for Asthma (GINA). Global strategy for asthma management and prevention. https://ginasthma.org/wp-content/uploads/2023/05/GINA-2023-Full-Report-2023-WMS.pdf. Updated 2023 (Accessed on June 13, 2023).</div><div id="graphicVersion">Graphic 68143 Version 26.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
